Muhammad Al-Hajj
Chief Tech/Sci/R&D Officer at IO BIOTECH, INC.
Net worth: - $ as of 2024-03-30
Profile
Muhammad Al-Hajj is currently the Chief Scientific Officer at IO Biotech, Inc. Prior to this, he worked as the Senior Director-Biology & Trans Med at GSK Plc from 2009 to 2015, and as the VP-Drug Discovery & Translational Medicine at Sanford Burnham Prebys Medical Discovery Institute from 2015 to 2017.
He also held the position of Senior Vice President-Translational Sciences at Autolus Ltd.
Dr. Al-Hajj earned a doctorate degree from the University of Michigan Comprehensive Cancer Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IO BIOTECH, INC.
-.--% | 2023-03-19 | 0 ( -.--% ) | - $ | 2024-03-30 |
Muhammad Al-Hajj active positions
| Companies | Position | Start |
|---|---|---|
| IO BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 2021-04-30 |
Former positions of Muhammad Al-Hajj
| Companies | Position | End |
|---|---|---|
Sanford Burnham Prebys Medical Discovery Institute
 Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 2017-05-31 |
| GSK PLC | Corporate Officer/Principal | 2015-03-31 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Corporate Officer/Principal | - |
Training of Muhammad Al-Hajj
| University of Michigan Comprehensive Cancer Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| IO BIOTECH, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Health Services |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Muhammad Al-Hajj
